YABATECH Research Team Secures N34 Million Grant to Revolutionize Prostate Cancer Treatment

The Yaba College of Technology (YABATECH) research team, armed with a N34 million grant, is on a mission to revolutionize prostate cancer treatment. Their groundbreaking project, titled “Artificial Intelligence-based Drip Combination Prediction and Ex vivo Screening against Prostate Cancer: Biopsy for Individualized Treatment,” promises hope for patients in Nigeria and beyond. By harnessing the power of AI, they seek to improve outcomes and make a lasting impact on humanity.

Feb 21, 2024 - 13:05 Updated: Feb 21, 2024 - 19:03

YABATECH Research Team Secures N34 Million Grant to Revolutionize Prostate Cancer Treatment

The Yaba College of Technology (YABATECH) research team has achieved a significant milestone in the fight against prostate cancer. With a recent grant award of N34 million from the National Research Fund (NRF) of the Tertiary Education Trust Fund (TETfund), they are poised to make a lasting impact on humanity and improve the quality of life for prostate cancer patients.

Prostate cancer remains one of the most prevalent cancers affecting males worldwide. Researchers are tirelessly exploring innovative treatment approaches to prevent, detect, and treat this disease. Among these dedicated scientists is the YABATECH team, comprising experts from diverse fields including Computer Engineering, Medical Biochemistry, Oncology, Pathology, Zoology, Pharmacognosy, Ethnopharmacy, Toxicology, and Pharmacology. Collaborators from Usmanu Danfodiyo University, Sokoto, and the University of Lagos join forces with YABATECH in this critical endeavor.

The groundbreaking research project, titled “Artificial Intelligence-based Drip Combination Prediction and Ex vivo Screening against Prostate Cancer: Biopsy for Individualized Treatment,” aims to revolutionize prostate cancer management. By harnessing the power of artificial intelligence (AI), the team will develop a precision medicine solution tailored to individual patients. This innovative approach holds the potential to significantly enhance treatment outcomes not only in Nigeria but globally.

Mrs. Aishat Oluwatosin Amolegbe, the Principal Investigator (PI) from the Department of Biological Science at YABATECH, emphasized the collective effort and dedication that led to this achievement. “Bringing everyone together,” she said, “was essential in realizing our planned objectives.”

With access to biopsy samples from consenting prostate cancer patients in Nigeria—a country with one of the highest prostate cancer rates—the YABATECH research team is poised to make a meaningful difference in the lives of those affected by this challenging disease.

As they embark on this critical mission, the YABATECH researchers stand at the forefront of advancing prostate cancer treatment through cutting-edge science and compassionate care. Their commitment to improving the quality of life for patients is commendable, and their work promises hope for a brighter future in the fight against cancer.